China News Service, Zhuhai, December 17 (Reporter Deng Yuanwen) On the 17th, the first anniversary of the establishment of the Chinese Medicine Preparation Center of Guangdong-Macao Medical Institutions (hereinafter referred to as the "Preparation Center") and the results conference was held at the Zhuhai Integrated Traditional Chinese and Western Medicine Hospital.
"Yiqi Ganlu Granules" as the first standardized research and development product of the preparation center has been included in the clinical drug catalog of Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine and officially promoted.
It is understood that the preparation center jointly built by the Guangdong-Macao Cooperation Traditional Chinese Medicine Science and Technology Industrial Park and Zhuhai Integrated Traditional Chinese and Western Medicine Hospital was inaugurated and established in Hengqin on December 17, 2019.
In March of this year, the Preparation Center obtained the "Medical Institution Preparation License" and obtained the production license for granules.
Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine selected the first batch of 8 agreed prescriptions from 97 empirical agreement prescriptions, and the center carried out technology development, production and quality control.
In December of this year, the Preparation Center was approved to expand the scope of preparation licenses, adding production licenses for tablets, pills, powders, liniments, and capsules.
“Over the past year, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine has worked together with the Guangdong-Macao Traditional Chinese Medicine Science and Technology Industrial Park to actively explore innovative models for the development and production of Chinese medicine preparations in medical institutions under the framework of one country, two systems.” said Li Zisong, party secretary of Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine , The clinical application of "Yiqi Ganlu Granules" has taken a solid step for the establishment of a system of consultation, co-construction and sharing of traditional Chinese medicine in Guangdong, Hong Kong and Macao.
According to Li Shaojie, vice president of Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, the formulation of "Yiqi Ganlu Granules" condensed the sixth batch of national veteran experts in traditional Chinese medicine to inherit the academic experience of the work instructor, Professor Liu Zhilong, the wisdom of traditional Chinese medicine. More than 20 years of clinical exploration, thousands of clinical cases, and more than 90% clinical cure rate and other efficacy verifications, it is a good medicine for the treatment of diabetes with definite efficacy and high safety.
Feng Zhun, deputy chief executive of Guangdong-Macao Traditional Chinese Medicine Science and Technology Industrial Park, said that the next step will be to use the advanced drug R&D, production and quality management system of Guangdong-Macao Traditional Chinese Medicine Science and Technology Industrial Park and its wholly-owned subsidiary, Guangdong-Macao Pharmaceutical Co., Ltd. Continue to advance the technology development, production and quality control of the first batch of 7 prescriptions to provide patients with more safe, effective and high-quality medical institution preparations.
(Finish)